These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 32154610

  • 21. [A Single-Center Analysis of the Use of G-CSF Combined with Plerixafor to Mobilize Peripheral Blood Hematopoietic Stem Cell from Healthy Related Donors in Allogeneic Hematopoietic Stem Cell Transplantation].
    Chen J, Yuan LL, Zhang X, Qiao JL, Yin QX, Zhang YM, Yang XL, Cao XY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):286-291. PubMed ID: 35123641
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Efficacy and Safety of Plerixafor Combined with G-CSF for Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization in Lymphoma Patients].
    Guan FS, He DH, Li Y, Zhang Y, Zheng GF, Zhu YY, He JS, Zhang EF, Cai Z, Zhao Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1056-1060. PubMed ID: 37551477
    [Abstract] [Full Text] [Related]

  • 24. The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.
    Girbl T, Lunzer V, Greil R, Namberger K, Hartmann TN.
    Transfusion; 2014 Sep; 54(9):2325-35. PubMed ID: 24673458
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma.
    Stewart DA, Smith C, MacFarland R, Calandra G.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):39-46. PubMed ID: 19135941
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plerixafor combined with standard regimens for hematopoietic stem cell mobilization in pediatric patients with solid tumors eligible for autologous transplants: two-arm phase I/II study (MOZAIC).
    Morland B, Kepak T, Dallorso S, Sevilla J, Murphy D, Luksch R, Yaniv I, Bader P, Rößler J, Bisogno G, Maecker-Kolhoff B, Lang P, Zwaan CM, Sumerauer D, Kriván G, Bernard J, Liu Q, Doyle E, Locatelli F.
    Bone Marrow Transplant; 2020 Sep; 55(9):1744-1753. PubMed ID: 32127657
    [Abstract] [Full Text] [Related]

  • 31. Autologous peripheral blood stem cell mobilization and collection in patients with lymphoma and multiple myeloma: A single-center experience using the plerixa for pre-emptive approach.
    Alsaeed AS, Najib MJ, Al Amoudi SM, Elhemaidi IY, Absi AA, Al Ahmadi MD, Eldadah SK, Rajkhan WA, Khalil MM, Almohammadi MH.
    Saudi Med J; 2022 Jun; 43(6):626-632. PubMed ID: 35675941
    [Abstract] [Full Text] [Related]

  • 32. Pre-emptive plerixafor injection increases blood neutrophil, lymphocyte and monocyte counts in addition to CD34+ counts in patients with non-Hodgkin lymphoma mobilizing poorly with chemotherapy plus G-CSF: potential implications for apheresis and graft composition.
    Varmavuo V, Mäntymaa P, Kuittinen T, Nousiainen T, Jantunen E.
    Transfus Apher Sci; 2012 Jun; 46(3):257-62. PubMed ID: 22465758
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era.
    Ishii A, Jo T, Arai Y, Oshima S, Kanda J, Kitawaki T, Matsui K, Niwa N, Nakagawa Y, Takaori-Kondo A, Nagao M.
    Cytotherapy; 2022 Jan; 24(1):49-58. PubMed ID: 34654641
    [Abstract] [Full Text] [Related]

  • 38. Plerixafor stem cell mobilization in Japanese children: A post-marketing study.
    Goto H, Kanamori R, Nishina S, Seto T.
    Pediatr Int; 2022 Jan; 64(1):e15106. PubMed ID: 35396889
    [Abstract] [Full Text] [Related]

  • 39. Plerixafor strategies for autologous hematopoietic cell transplant mobilization: A comparison of efficacy and cost.
    Chen KY, Bucci TG, Shaw JR, Alexander MD, Grgic T, Riches M, Ptachcinski JR.
    Transfus Apher Sci; 2022 Apr; 61(2):103303. PubMed ID: 34801430
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.